Hmg (Human Menopausal Gonadotropin) — reference
Mixed FSH/LH gonadotropin preparation used in fertility treatment.
Regulatory status
FDA-Approved (labeled use). FDA-approved for fertility indications (e.g. Menopur). Any use outside that is off-label.
Reported cautions
Pharmacokinetics
Published figures give an elimination half-life of Variable — FSH component ~3–4h (alpha) / up to ~70h (terminal beta). Mixed gonadotropin product; complex biphasic PK, not a single clean number.
This figure is tagged PK study in our evidence system. This figure comes from a published pharmacokinetic study rather than a label or registration trial. Sample sizes in such studies are often small and figures vary between them, so treat the number as a range rather than a constant. You can see the shape this implies between doses in the Half-Life Visualizer, and compare it against every other compound in the Half-Life Data Table. Our sourcing page explains what each tier means.
Remember that an estimated curve is a model built from a population figure, not a measurement of your blood. Individual clearance varies, and for depot injections the figure describes release from the injection site rather than the compound clearing. Half-life explained →
What Peptide Plug does and does not publish
This page carries regulatory status, general context and published pharmacokinetics. It carries no dose, frequency or cycle information — that is a deliberate editorial line, because dosing is a clinical decision rather than reference data. We also do not sell, supply, source or link to vendors for any compound.
Frequently asked
Is Hmg (Human Menopausal Gonadotropin) FDA-approved?
What is the half-life of Hmg (Human Menopausal Gonadotropin)?
How reliable is that half-life figure?
What cautions are associated with Hmg (Human Menopausal Gonadotropin)?
Does Peptide Plug publish dosing for Hmg (Human Menopausal Gonadotropin)?
Does Peptide Plug sell Hmg (Human Menopausal Gonadotropin)?
Related tools
Free, no account required.